A selective cytopheretic inhibitory device for use during cardiopulmonary bypass surgery

Perfusion (United Kingdom)

Volumn 27, Issue 4, 2012, Pages 311-319

  Pino, C J ^a   Lou, L ^a   Smith, P L ^a   Ding, F ^a,b,c   Pagani, F D ^b   Buffington, D A ^a   Humes, H D ^a,b,d  

^a Innovative BioTherapies Inc   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c FUDAN UNIVERSITY   (China)

^d CytoPherx Inc   (United States)

Author keywords

biomimetic; cardiac surgery; cardiopulmonary bypass; leukoreduction; selective cytopheretic device

Indexed keywords

BIOMIMETIC MATERIAL; CITRIC ACID;

ADOLESCENT; ANIMAL EXPERIMENT; ARTICLE; BIOCOMPATIBILITY; BLOOD COMPONENT; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; COW; CYTAPHERESIS; DEVICES; ELUTION; FILTER; HEART ASSIST DEVICE; HEMOLYSIS; IMPLANTATION; LEUKOCYTE ACTIVATION; NEUTROPHIL; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; SAFETY; SELECTIVE CYTOPHERETIC DEVICE;

ANIMALS; CARDIOPULMONARY BYPASS; CATTLE; HUMANS; LEUKAPHERESIS; LEUKOCYTE COUNT; MULTIPLE ORGAN FAILURE; NEUTROPHILS; OPERATIVE BLOOD SALVAGE;

EID: 84862861526     PISSN: 02676591     EISSN: 1477111X     Source Type: Journal    
DOI: 10.1177/0267659112444944     Document Type: Article

References (25)

1. Brown KA, Brain SD, Pearson JD, Edgeworth JD, Lewis SM, Treacher DF.. Neutrophils in development of multiple organ failure in sepsis. Lancet. 2006 ; 368 (9530). 157-169
2. Marshall JC.. Neutrophils in the pathogenesis of sepsis. Crit Care Med. 2005 ; 33: S502-505
3. Maroszynsk I, Fiedor P. Leukocytes and endothelium interaction as rate limiting step in the inflammatory response and a key factor in the ischemia-reperfusion injury. Ann Transplant. 2000 ; 5 (4). 5-11
4. Wan S, LeClerc JL, Vincent JL.. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest. 1997 ; 112 (3). 676-692
5. Asimakopoulos G, Smith PL, Ratnatunga CP, Taylor KM.. Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass. Ann Thorac Surg. 1999 ; 68 (3). 1107-1115
6. Picone AL, Lutz CJ, Finck C, et al. Multiple sequential insults cause post-pump syndrome. Ann Thorac Surg. 1999 ; 67 (4). 978-985
7. Clark SC.. Lung injury after cardiopulmonary bypass. Perfusion. 2006 ; 21 (4). 225-228
8. Messent M, Sullivan K, Keogh BF, Morgan CJ, Evans TW.. Adult respiratory distress syndrome following cardiopulmonary bypass: incidence and prediction. Anaesthesia. 1992 ; 47 (3). 267-268
9. Parikh CR, Mishra J, Thiessen-Philbrook H, et al. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int. 2006 ; 70 (1). 199-203
10. Warren OJ, Tunnicliffe CR, Massey RM, et al. Systemic leukofiltration does not attenuate pulmonary injury after cardiopulmonary bypass. ASAIO J. 2008 ; 54 (1). 78-88
11. Baksaas ST, Flom-Halvorsen HI, Ovrum E, et al. Leucocyte filtration during cardiopulmonary bypass hardly changed leucocyte counts and did not influence myeloperoxidase, complement, cytokines or platelets. Perfusion. 1998 ; 13 (6). 429-436
12. Hurst T, Johnson D, Cujec B, et al. Depletion of activated neutrophils by a filter during cardiac valve surgery. Can J Anaesth. 1997 ; 44 (2). 131-139
13. Karaiskos TE, Palatianos GM, Triantafillou CD, et al. Clinical effectiveness of leukocyte filtration during cardiopulmonary bypass in patients with chronic obstructive pulmonary disease. Ann Thorac Surg 200. 78 (4). 1339-1344
14. Mihaljevic T, Tönz M, von Segesser LK, et al. The influence of leukocyte filtration during cardiopulmonary bypass on postoperative lung function. A clinical study. J Thorac Cardiovasc Surg. 1995 ; 109 (6). 1138-1145
15. Scholz M, Simon A, Matheis G, et al. Leukocyte filtration fails to limit functional neutrophil activity during cardiac surgery. Inflamm Res. 2002 ; 51 (7). 363-368
16. Stefanou DC, Gourlay T, Asimakopoulos G, Taylor KM. Leucodepletion during cardiopulmonary bypass reduces blood transfusion and crystalloid requirements. Perfusion. 2001 ; 16 (1). 51-58
17. Warren O, Alexiou C, Massey R, et al. The effects of various leukocyte filtration strategies in cardiac surgery. Eur J Cardiothorac Surg. 2007 ; 31 (4). 665-676
18. Smit JJ, de Vries AJ, Gu YJ, van Oeveren W.. Efficiency and safety of leukocyte filtration during cardiopulmonary bypass for cardiac surgery. Transfus Sci. 1999 ; 20 (3). 151-165
19. Alexiou C, Tang AA, Sheppard SV, et al. The effect of leucodepletion on leucocyte activation, pulmonary inflammation and respiratory index in surgery for coronary revascularisation: a prospective randomised study. Eur J Cardiothorac Surg. 2004 ; 26 (2). 294-300
20. Humes HD, Sobota JT, Ding F, Song JH. A selective cytopheretic inhibitory device to treat the immunological dysregulation of acute and chronic renal failure. Blood Purif. 2010 ; 29 (2). 183-190
21. Ding F, Yevzlin AS, Xu ZY, et al. The effects of a novel therapeutic device on acute kidney injury outcomes in the intensive care unit: a pilot study. ASAIO J. 2011 ; 57 (5). 426-432
22. Fietz S, Bondzio A, Moschos A, Hertsch B, Einspanier R.. Measurement of equine myeloperoxidase (MPO) activity in synovial fluid by a modified MPO assay and evaluation of joint diseases - an initial case study. Res Vet Sci. 2008 ; 84 (3). 347-353
23. Kumar P, Pai K, Pandey HP, Sundar S.. NADH-oxidase, NADPH-oxidase and myeloperoxidase activity of visceral leishmaniasis patients. J Med Microbiol. 2002 ; 51 (10). 832-836
24. Ding F, Song JH, Jung JY, et al. A biomimetic membrane device that modulates the excessive inflammatory response to sepsis. PLoS ONE. 2011 ; 6 (4). e18584
25. Belway D, Tee R, Nathan HJ, Rubens FD, Boodhwani M.. Temperature management and monitoring practices during adult cardiac surgery under cardiopulmonary bypass: results of a Canadian national survey. Perfusion. 2011 ; 26 (5). 395-400